Hiroyuki Nishiyama
Overview
Explore the profile of Hiroyuki Nishiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
440
Citations
3409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki S, Nagumo Y, Kojo K, Kandori S, Sakurai H, Takahashi R, et al.
BMC Cancer
. 2025 Mar;
25(1):464.
PMID: 40082801
Background: To clarify the long-term prognoses of elderly upper tract urothelial carcinoma (UTUC) patients after surgery. Methods: We used a hospital-based cancer registry data in Japan to extract patients with...
2.
Tanaka T, Kojo K, Suetomi T, Nagumo Y, Midorikawa H, Matsuda T, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077734
: Modern societal stressors have been linked to declining testosterone levels among young men, contributing to somatic, psychological, and sexual health problems. Despite growing evidence suggesting a link between trace...
3.
Tohi Y, Yokomizo A, Kimura T, Wakabayashi M, Shiota M, Mori K, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40056276
Background: We have demonstrated that patients with prostate-specific antigen failure following radical prostatectomy benefit from salvage radiation therapy prior to salvage hormone therapy in a multicenter, randomized, open-label, phase 3...
4.
5.
Ohba K, Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, et al.
Int J Clin Oncol
. 2025 Feb;
PMID: 39951188
Background: Axitinib is a widely used tyrosine kinase inhibitor (TKI) in metastatic renal cell carcinoma (mRCC) treatment. Here, we analyzed the characteristics of patients who did not respond to axitinib...
6.
Kanno T, Ito K, Kita Y, Mochizuki T, Sano T, Yokomizo A, et al.
Int J Urol
. 2025 Feb;
PMID: 39930591
Objectives: The impact of lymph node dissection (LND) on the efficacy of pembrolizumab in patients with urothelial carcinoma (UC) who develop metastasis after surgery remains unclear. This study aimed to...
7.
Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, et al.
Int J Urol
. 2025 Feb;
PMID: 39907200
Objective: To examine the association between substaging and outcomes following radical cystectomy (RC) in patients with stage III bladder cancer. Methods: We conducted a retrospective observational study using nationwide data...
8.
Kawahara T, Kandori S, Kojima T, Mathis B, Shiga M, Nishiyama H
BMC Res Notes
. 2025 Jan;
18(1):47.
PMID: 39891237
Objective: Recent preclinical and retrospective clinical evidence shows that androgen receptor (AR)-mediated signals have significant roles in development of non-muscle invasive bladder cancer (NMIBC). Here, we conducted a single-center, phase...
9.
Kandori S, Suzuki S, Kojo K, Isoda B, Tanaka T, Nitta S, et al.
BMC Cancer
. 2025 Jan;
25(1):138.
PMID: 39849400
Background: To identify the prognosis of Japanese patients with collecting duct carcinoma (CDC). Methods: We used a hospital-based cancer registry data in Japan to extract CDC cases that were diagnosed...
10.
Suzuki S, Negoro H, Kubota M, Sumiyoshi T, Saito R, Okuno T, et al.
Sci Rep
. 2025 Jan;
15(1):2025.
PMID: 39815039
This study evaluated the impact of aspirin on the biochemical recurrence (BCR) rate following robot-assisted radical prostatectomy (RARP) in patients. A database search identified patients who underwent RARP for pT2-3N0M0...